News Story: Full Text
Sponsored By
Tocagen Clinical Trial
Please Click On The Above Banner For More Details
Braintumor Website

 

Diffusion Pharmaceuticals seeks Wall Street investment while staying local

Al's Comment:

 This is an important trial.  In the phase 2 trial, on newly diagnosed GBM patients who only had biopsies - not subtotal resection or complete resection, they had "in patients with inoperable tumors, who demonstrated a 380 percent increase in survival at two years."

This is so important that I am including it in my presentation to the FDA next week as an example of a drug that needs to be approved quickly!


Posted on: 06/18/2017

 


Click HERE to return to brain tumor news headlines


Home | Brain Tumor Guide | FAQs | Find A Treatment
Noteworthy Treatments | News | Virtual Trial | Videos | Novocure Optune® | Newsletter
Donations | Brain Tumor Centers | Survivor Stories | Temodar®
Fundraising For Research | Unsubscribe | Contact Us

Copyright (c) 1993 - 2018 by:
The Musella Foundation For Brain Tumor Research & Information, Inc
1100 Peninsula Blvd
Hewlett, NY 11557
888-295-4740